CVRX CVRx, Inc. - Common Stock
NASDAQ · Health Care · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$1,55
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,50rendah 52m
$11,30tinggi 52m
Kapitalisasi Pasar (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
Pendapatan (TTM)
$61M
lencana Anda
Rentang 52M
$2–$11
Peringkat Analis
BUY
Target Harga
$5
P/E
-0.8
ROE
-133.4%
Margin Laba Bersih
-84.9%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CVRX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.55
Kapitalisasi Pasar (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
Pendapatan (TTM)
$61M
ROE (TTM)
-133.4%
D/E Utang/Ekuitas (MRQ)
2.9
Rentang 52M
$2–$11
CVRX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang CVRx, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
sektorHealth Care
industriHealth Care
karyawan223
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$57M2020-12-31 → 2025-12-31
EPS$-2.042021-12-31 → 2025-12-31
Arus Kas Bebas$-41M2021-12-31 → 2025-12-31
Margin bersih-84.9%2021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CVRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -0.8rata-rata 5T ≈-7.2 | ≈-7.2 | · | · | |
| P/S (TTM) | 0.7rata-rata 5T ≈12.4 | ≈12.4 | 2.2 | Nilai wajar | |
| P/B (MRQ) | 2.1rata-rata 5T ≈4.6 | ≈4.6 | 3.8 | Terlalu mahal | |
| EV / EBITDA | -0.3rata-rata 5T ≈-6.4 | ≈-6.4 | · | · | |
| Harga / FCF (TTM) | -1.0rata-rata 5T ≈-9.3 | ≈-9.3 | · | · | |
| Harga / Arus Kas (TTM) | -1.0rata-rata 5T ≈-9.5 | ≈-9.5 | · | · | |
| EV / Revenue (EV / Pendapatan) | 0.3rata-rata 5T ≈8.8 | ≈8.8 | · | · | |
| EV / FCF | -0.4rata-rata 5T ≈-7.1 | ≈-7.1 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.0rata-rata 5T ≈4.6 | ≈4.6 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CVRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Kotor (TTM) | 86.9%rata-rata 5T ≈80.6% | ≈80.6% | 37.9% | Tingkat teratas | |
| Margin Operasi (TTM) | -79.5%rata-rata 5T ≈-140.9% | ≈-140.9% | -18.1% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -90.5%rata-rata 5T ≈-140.9% | ≈-140.9% | -17.5% | Lemah | |
| Margin Sebelum Pajak (TTM) | -84.9%rata-rata 5T ≈-165.8% | ≈-165.8% | -11.6% | Lemah | |
| Margin Laba Bersih (TTM) | -84.9%rata-rata 5T ≈-166.1% | ≈-166.1% | -50.8% | Di bawah rata-rata | |
| ROA (TTM) | -49.1%rata-rata 5T ≈-39.4% | ≈-39.4% | -13.7% | Lemah | |
| ROE (TTM) | -133.4%rata-rata 5T ≈-62.9% | ≈-62.9% | -81.1% | Lemah | |
| ROIC | -57.7%rata-rata 5T ≈-40.6% | ≈-40.6% | -16.7% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CVRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 2.9rata-rata 5T ≈0.5 | ≈0.5 | 1.8 | Di atas rata-rata | |
| Rasio Lancar (MRQ) | 8.0rata-rata 5T ≈14.9 | ≈14.9 | 2.7 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 6.5rata-rata 5T ≈13.6 | ≈13.6 | 1.9 | Likuiditas kuat | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 2.9rata-rata 5T ≈0.5 | ≈0.5 | 2.9 | Sejajar |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | CVRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 10.4%rata-rata 5T ≈60.7% | ≈60.7% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 36.1%rata-rata 5T ≈60.2% | ≈60.2% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 56.4% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | CVRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.5rata-rata 5T ≈0.3 | ≈0.3 | 0.7 | Lemah | |
| Inventory Turnover (Perputaran Persediaan) | 0.7rata-rata 5T ≈0.8 | ≈0.8 | 2.3 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 5.7rata-rata 5T ≈6.0 | ≈6.0 | 5.8 | Sejajar | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$254.0K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.1%
Laporan Berikutnya
Nov 03, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 3, 2026 | $-0.53 | $-0.53 | 0.90% |
| 31 Maret 2026 | $-0.50 | $-0.51 | 2.8% | |
| 31 Des. 2025 | $-0.46 | $-0.45 | -2.8% | |
| 30 Sep. 2025 | $-0.49 | $-0.51 | 4.2% | |
| 30 Juni 2025 | $-0.57 | $-0.53 | -7.5% | |
| 31 Maret 2025 | $-0.53 | $-0.58 | 8.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $57M | $51M | $39M | $22M | $13M | $6M | |
| Cost of Revenue | $8M | $8M | $6M | $5M | $4M | $1M | |
| Gross Profit | $48M | $43M | $33M | $17M | $9M | $5M | |
| R&D Expense | $11M | $11M | $12M | $10M | $8M | $6M | |
| SG&A Expense | $88M | $91M | $65M | $50M | $28M | $10M | |
| Operating Expenses | $100M | $102M | $76M | $60M | $35M | $16M | |
| Operating Income | $-51M | $-59M | $-43M | $-43M | $-26M | $-12M | |
| Interest Expense | · | · | $2M | $165.0K | $2M | $2M | |
| Other Non-op | $4M | $4M | $4M | $1M | $-15M | $-40.0K | |
| Pretax Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| Income Tax | $-18.0K | $55.0K | $147.0K | $109.0K | $91.0K | $85.0K | |
| Net Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| EPS (Basic) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| EPS (Diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| Shares (Basic) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| Shares (Diluted) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| EBITDA | $-51M | $-59M | $-43M | $-43M | $-26M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $106M | $91M | $106M | $142M | $59M | |
| Receivables | $11M | $9M | $8M | $6M | $3M | $1M | |
| Inventory | $12M | $12M | $11M | $7M | $4M | $3M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $605.0K | |
| Current Assets | $102M | $130M | $112M | $123M | $151M | $64M | |
| PP&E (Net) | $2M | $3M | $2M | $2M | $1M | $410.0K | |
| PP&E (Gross) | $6M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | |
| Total Assets | $105M | $133M | $115M | $125M | $153M | $65M | |
| Accounts Payable | $4M | $3M | $2M | $2M | $510.0K | $483.0K | |
| Accrued Liabilities | $9M | $8M | $6M | $6M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $8M | $8M | $6M | $8M | |
| Capital Leases | $638.0K | $877.0K | $1M | $117.0K | $0 | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $805.0K | $681.0K | $777.0K | |
| Total Liabilities | $65M | $62M | $39M | $16M | $7M | $28M | |
| Long-term Debt | · | · | · | · | · | $19M | |
| Total Debt | $50M | $49M | $29M | $7M | $0 | · | |
| Common Stock | $263.0K | $253.0K | $209.0K | $207.0K | $204.0K | $4.0K | |
| Retained Earnings | $-591M | $-537M | $-477M | $-436M | $-395M | $-352M | |
| AOCI | $-203.0K | $-206.0K | $-207.0K | $-207.0K | $-198.0K | $-190.0K | |
| Stockholders' Equity | $39M | $71M | $76M | $109M | $146M | $-293M | |
| Liabilities + Equity | $105M | $133M | $115M | $125M | $153M | $65M | |
| Shares Outstanding | 26,311,607 | 25,324,684 | 20,879,199 | 20,663,736 | 20,399,337 | 360,412 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $19M | $6M | $4M | $2M | $132.0K | |
| Operating Cash Flow | $-40M | $-39M | $-39M | $-43M | $-28M | $-16M | |
| CapEx | $580.0K | $1M | $591.0K | $685.0K | $1M | $311.0K | |
| Investing Cash Flow | $-580.0K | $-1M | $-591.0K | $-685.0K | $-1M | $-311.0K | |
| Net Debt Issued | · | · | · | $0 | $-21M | · | |
| Stock Issued | $9M | $33M | $0 | $0 | $133M | $0 | |
| Net Stock Activity | $9M | $33M | · | $0 | $133M | · | |
| Financing Cash Flow | $11M | $56M | $24M | $7M | $112M | $50M | |
| Net Change in Cash | $-30M | $15M | $-16M | $-36M | $83M | $33M | |
| Free Cash Flow | $-41M | $-41M | $-40M | $-43M | $-29M | · | |
| Levered FCF | · | · | $-41M | $-44M | $-31M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% | · | |
| Operating Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| Net Margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.4% | · | |
| Pretax Margin | -94.1% | -116.8% | -104.5% | -183.9% | -329.8% | · | |
| EBITDA Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| ROA | -44.8% | -48.2% | -34.3% | -29.9% | -39.6% | · | |
| ROE | -109.6% | -88.0% | -51.9% | -36.4% | -28.5% | · | |
| ROIC | -57.7% | -49.5% | -41.1% | -36.8% | -17.8% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 | · | |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 | · | |
| Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| LT Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| Interest Coverage | · | · | -24.0 | -257.7 | -11.7 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.2 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | · | |
| Receivables Turnover | 5.7 | 6.1 | 6.0 | 5.6 | 6.8 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.49 | $2.81 | $3.64 | $5.29 | $7.16 | · | |
| Revenue / Share | $2.17 | $2.27 | $1.89 | $1.09 | · | · | |
| Cash Flow / Share | $-1.54 | $-1.73 | $-1.88 | $-2.08 | · | · | |
| Cash / Share | $2.88 | $4.18 | $4.34 | $5.15 | $6.96 | · | |
| EPS (TTM) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.4% | 30.5% | 74.9% | 72.4% | 115.4% | · | |
| Revenue CAGR 3Y | 36.1% | 57.9% | 86.6% | · | · | · | |
| Revenue CAGR 5Y | 56.4% | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $57M | $51M | $39M | $22M | $13M | · | |
| Net Income TTM | $-53M | $-60M | $-41M | $-41M | $-43M | · | |
| Market Cap | $187M | $321M | $656M | $379M | $249M | · | |
| Enterprise Value | $161M | $264M | $595M | $279M | $107M | · | |
| P/E | -3.5 | -4.8 | -15.8 | -9.1 | -2.9 | · | |
| P/S | 3.3 | 6.3 | 16.7 | 16.9 | 19.1 | · | |
| P/B | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Tangible Book | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Cash Flow | -4.7 | -8.2 | -16.8 | -8.9 | -9.0 | · | |
| P / FCF | -4.6 | -7.9 | -16.6 | -8.7 | -8.6 | · | |
| EV / EBITDA | -3.1 | -4.4 | -13.8 | -6.6 | -4.1 | · | |
| EV / FCF | -3.9 | -6.5 | -15.0 | -6.4 | -3.7 | · | |
| EV / Revenue | 2.8 | 5.2 | 15.1 | 12.4 | 8.2 | · | |
| Earnings Yield | -28.7% | -20.9% | -6.3% | -11.0% | -34.0% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | $16M | $15M | $14M | $12M | $15M | $13M | $12M | $11M | $11M | $11M | $10M | $8M | $7M | $6M | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | |
| Gross Profit | $14M | $13M | $14M | $13M | $11M | $10M | $13M | $11M | $10M | $9M | $10M | $9M | $8M | $7M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $24M | $22M | $22M | $22M | $23M | $21M | $20M | $22M | $21M | $28M | $17M | $16M | $16M | $15M | $14M | $13M | |
| Operating Expenses | $27M | $25M | $25M | $25M | $26M | $24M | $23M | $24M | $24M | $31M | $19M | $18M | $20M | $19M | $17M | $15M | |
| Operating Income | $-13M | $-12M | $-11M | $-12M | $-14M | $-13M | $-10M | $-13M | $-14M | $-22M | $-10M | $-10M | $-12M | $-12M | $-11M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $960.0K | · | $499.0K | $481.0K | $240.0K | $165.0K | $0 | |
| Other Non-op | $560.0K | $593.0K | $660.0K | $875.0K | $1M | $1M | $1M | $917.0K | $944.0K | $1M | $1M | $1M | $616.0K | $1M | $1M | $328.0K | |
| Pretax Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $3.0K | $1.0K | $-7.0K | $-3.0K | $-3.0K | $-5.0K | $-71.0K | $47.0K | $41.0K | $38.0K | $39.0K | $40.0K | $34.0K | $34.0K | $28.0K | $32.0K | |
| Net Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| EPS (Diluted) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| Shares (Basic) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| Shares (Diluted) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| EBITDA | $-13M | $-12M | · | $-12M | $-14M | $-13M | · | $-13M | $-14M | $-22M | · | $-10M | $-12M | $-12M | · | $-10M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $72M | $76M | $85M | $95M | $103M | $106M | $100M | $70M | $80M | $91M | $83M | $91M | $103M | $106M | $110M | |
| Receivables | $9M | $9M | $11M | $8M | $7M | $9M | $9M | $9M | $9M | $8M | $8M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $13M | $12M | $12M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $11M | $8M | $7M | $6M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Current Assets | $89M | $97M | $102M | $108M | $116M | $126M | $130M | $124M | $92M | $102M | $112M | $104M | $112M | $121M | $123M | $124M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | |
| Total Assets | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Accounts Payable | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $7M | $6M | $9M | $8M | $7M | $6M | $8M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Current Liabilities | $11M | $9M | $13M | $11M | $10M | $9M | $11M | $11M | $9M | $8M | $8M | $7M | $9M | $8M | $8M | $7M | |
| Capital Leases | $448.0K | $544.0K | $638.0K | $730.0K | $819.0K | $802.0K | $877.0K | $951.0K | $1M | $1M | $1M | $916.0K | $946.0K | $59.0K | $117.0K | $175.0K | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $960.0K | $885.0K | $815.0K | $805.0K | $761.0K | |
| Total Liabilities | $72M | $71M | $65M | $63M | $62M | $60M | $62M | $62M | $41M | $40M | $39M | $24M | $25M | $23M | $16M | $8M | |
| Total Debt | $59M | $58M | · | $49M | $49M | $49M | · | $49M | $29M | $29M | · | $14M | $14M | $14M | · | · | |
| Common Stock | $266.0K | $264.0K | $263.0K | $262.0K | $261.0K | $261.0K | $253.0K | $242.0K | $217.0K | $216.0K | $209.0K | $208.0K | $208.0K | $207.0K | $207.0K | $206.0K | |
| Retained Earnings | $-618M | $-604M | $-591M | $-579M | $-566M | $-551M | $-537M | $-527M | $-514M | $-500M | $-477M | $-468M | $-459M | $-448M | $-436M | $-426M | |
| AOCI | $-204.0K | $-203.0K | $-203.0K | $-204.0K | $-203.0K | $-205.0K | $-206.0K | $-208.0K | $-210.0K | $-210.0K | $-207.0K | $-208.0K | $-187.0K | $-204.0K | $-207.0K | $-219.0K | |
| Stockholders' Equity | $20M | $29M | $39M | $48M | $58M | $69M | $71M | $65M | $55M | $66M | $76M | $83M | $90M | $100M | $109M | $118M | |
| Liabilities + Equity | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Shares Outstanding | 26,641,597 | 26,428,767 | 26,311,607 | 26,193,733 | 26,145,951 | 26,051,992 | 25,324,684 | 24,203,658 | 21,712,357 | 21,593,173 | 20,879,199 | 20,813,612 | 20,750,910 | 20,708,940 | 20,663,736 | 20,578,963 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $11M | $2M | $2M | $1M | $2M | $1M | $929.0K | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-10M | $-8M | $-13M | $-8M | $-10M | $-10M | $-11M | $-8M | $-8M | $-13M | $-10M | $-11M | $-11M | |
| CapEx | $112.0K | $122.0K | $68.0K | $295.0K | $103.0K | $114.0K | $52.0K | $37.0K | $355.0K | $917.0K | $169.0K | $39.0K | $143.0K | $240.0K | $79.0K | $264.0K | |
| Investing Cash Flow | $-112.0K | $-122.0K | $-68.0K | $-295.0K | $-103.0K | $-114.0K | $-52.0K | $-37.0K | $-355.0K | $-917.0K | $-169.0K | $-39.0K | $-143.0K | $-240.0K | $-79.0K | $-264.0K | |
| Stock Issued | $739.0K | $-43.0K | $-179.0K | $-45.0K | $0 | $9M | $12M | $20M | $-1.0K | $547.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-43.0K | · | · | · | $9M | · | · | · | $547.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $9M | $410.0K | $103.0K | $392.0K | $10M | $14M | $40M | $472.0K | $1M | $16M | $363.0K | $473.0K | $8M | $7M | $7.0K | |
| Net Change in Cash | $-8M | $-3M | $-9M | $-10M | $-8M | $-3M | $6M | $30M | $-10M | $-10M | $8M | $-8M | $-12M | $-3M | $-4M | $-11M | |
| Free Cash Flow | · | $-12M | · | · | · | $-13M | · | · | · | $-12M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-11M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.4% | 87.2% | · | 86.8% | 84.3% | 83.5% | · | 83.2% | 83.9% | 85.0% | · | 83.9% | 84.0% | 83.4% | · | 78.3% | |
| Operating Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| Net Margin | -89.4% | -88.8% | · | -87.6% | -108.4% | -111.5% | · | -98.0% | -118.8% | -206.0% | · | -85.7% | -122.6% | -142.6% | · | -158.9% | |
| Pretax Margin | -89.4% | -88.8% | · | -87.6% | -108.5% | -111.5% | · | -97.6% | -118.5% | -205.7% | · | -85.4% | -122.3% | -142.1% | · | -158.4% | |
| EBITDA Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| ROA | -13.3% | -11.4% | · | -10.8% | -13.7% | -11.7% | · | -11.2% | -13.3% | -19.4% | · | -7.7% | -9.4% | -8.5% | · | -6.4% | |
| ROE | -36.1% | -26.7% | · | -22.7% | -26.0% | -20.3% | · | -17.7% | -19.3% | -26.8% | · | -9.0% | -10.7% | -9.6% | · | -7.2% | |
| ROIC | -16.6% | -13.9% | · | -12.6% | -13.4% | -11.3% | · | -11.4% | -16.6% | -23.3% | · | -9.8% | -11.3% | -10.7% | · | -8.6% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 10.2 | · | 9.6 | 12.0 | 14.8 | · | 11.3 | 10.1 | 12.2 | · | 14.0 | 12.6 | 15.2 | · | 16.8 | |
| Quick Ratio | 6.7 | 8.6 | · | 8.3 | 10.5 | 13.1 | · | 10.0 | 8.7 | 10.6 | · | 12.1 | 10.9 | 13.8 | · | 15.6 | |
| Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -23.2 | · | -19.1 | -24.4 | -50.7 | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.9 | 1.6 | · | 1.7 | 1.7 | 1.4 | · | 1.7 | 1.5 | 1.4 | · | 1.8 | 1.8 | 1.6 | · | 1.4 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.75 | $1.10 | · | $1.83 | $2.22 | $2.66 | · | $2.69 | $2.54 | $3.07 | · | $3.98 | $4.34 | $4.81 | · | $5.75 | |
| Revenue / Share | $0.59 | $0.56 | · | $0.56 | $0.52 | $0.48 | · | $0.59 | $0.55 | $0.51 | · | $0.51 | $0.46 | $0.39 | · | $0.30 | |
| Cash Flow / Share | · | $-0.46 | · | · | · | $-0.49 | · | · | · | $-0.51 | · | · | · | $-0.50 | · | · | |
| Cash / Share | $2.42 | $2.74 | · | $3.25 | $3.63 | $3.94 | · | $4.14 | $3.24 | $3.71 | · | $3.99 | $4.38 | $4.99 | · | $5.34 | |
| EPS (TTM) | $-1.97 | $-2.01 | · | $-1.98 | $-2.06 | $-2.14 | · | $-2.71 | $-2.57 | $-2.48 | · | $-2.05 | $-2.10 | $-2.08 | · | $67.03 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | $59M | · | $56M | $55M | $53M | · | $47M | $44M | $42M | · | $35M | $31M | $26M | · | $19M | |
| Net Income TTM | $-52M | $-53M | · | $-52M | $-52M | $-52M | · | $-58M | $-54M | $-52M | · | $-43M | $-43M | $-43M | · | $-41M | |
| Market Cap | $137M | $250M | · | $211M | $154M | $319M | · | $213M | $260M | $393M | · | $316M | $320M | $193M | · | $192M | |
| Enterprise Value | $131M | $236M | · | $176M | $108M | $265M | · | $162M | $219M | $342M | · | $247M | $244M | $104M | · | · | |
| P/E | -2.6 | -4.7 | · | -4.1 | -2.9 | -5.7 | · | -3.3 | -4.7 | -7.3 | · | -7.4 | -7.4 | -4.5 | · | 0.1 | |
| P/S | 2.2 | 4.2 | · | 3.8 | 2.8 | 6.0 | · | 4.5 | 5.9 | 9.3 | · | 9.0 | 10.4 | 7.3 | · | 10.1 | |
| P/B | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Tangible Book | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Cash Flow | · | -20.6 | · | · | · | -25.0 | · | · | · | -36.1 | · | · | · | -18.8 | · | · | |
| EV / Revenue | 2.1 | 4.0 | · | 3.1 | 2.0 | 5.0 | · | 3.4 | 4.9 | 8.1 | · | 7.0 | 7.9 | 3.9 | · | · | |
| Earnings Yield | -38.3% | -21.2% | · | -24.5% | -35.0% | -17.5% | · | -30.8% | -21.4% | -13.6% | · | -13.5% | -13.6% | -22.3% | · | 718.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $57M | $51M | $39M | $22M | $13M |
| Margin Kotor % | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% |
| Margin Operasi % | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% |
| Laba Bersih | $-53M | $-60M | $-41M | $-41M | $-43M |
| EPS Dilusian | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 |
| Rasio Lancar | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 |
| Rasio Cepat | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-41M | $-41M | $-40M | $-43M | $-29M |
Pemilik institusional (13F) 95 pengaju · $87.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
95
Nilai yang dipegang
$87.3M
Posisi baru
8
Posisi yang keluar
18
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 8 (-19 vs Kuartal sebelumnya) | 18 (+5 vs Kuartal sebelumnya) | 35 (+2 vs Kuartal sebelumnya) | 29 (+9 vs Kuartal sebelumnya) | +574K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| JOHNSON & JOHNSON | $20.687.786 | 4.024.861 | 23,70% | Saham |
| NEA Management Company, LLC | $10.045.822 | 1.954.440 | 11,51% | Saham |
| VANGUARD GROUP INC | $7.956.707 | 1.120.663 | 9,12% | Saham |
| BlackRock, Inc. | $6.401.661 | 1.245.459 | 7,33% | Saham |
| ROYAL BANK OF CANADA | $6.338.000 | 1.233.212 | 7,26% | Saham |
| GSK plc | $5.178.977 | 1.007.583 | 5,93% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.680.361 | 910.576 | 5,36% | Saham |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $4.513.480 | 878.109 | 5,17% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $2.266.478 | 440.786 | 2,60% | Saham |
| PFM Health Sciences, LP | $1.899.600 | 369.572 | 2,18% | Saham |
| STATE STREET CORP | $1.883.049 | 366.352 | 2,16% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.182.200 | 230.000 | 1,35% | Saham |
| UBS Group AG | $1.152.558 | 224.233 | 1,32% | Saham |
| TUDOR INVESTMENT CORP ET AL | $1.057.216 | 205.684 | 1,21% | Saham |
| GOLDMAN SACHS GROUP INC | $768.476 | 149.509 | 0,88% | Saham |
| MORGAN STANLEY | $745.182 | 144.977 | 0,85% | Saham |
| Kestra Advisory Services, LLC | $680.536 | 132.400 | 0,78% | Saham |
| TWO SIGMA INVESTMENTS, LP | $680.526 | 132.398 | 0,78% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $662.829 | 128.955 | 0,76% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $659.866 | 127.971 | 0,76% | Saham |
| NORTHERN TRUST CORP | $641.302 | 124.767 | 0,73% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $544.403 | 105.915 | 0,62% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $542.856 | 105.614 | 0,62% | Saham |
| Cresset Asset Management, LLC | $533.784 | 103.849 | 0,61% | Saham |
| AlphaQuest LLC | $502.645 | 70.795 | 0,58% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $500.168 | 97.309 | 0,57% | Saham |
| Quantinno Capital Management LP | $423.192 | 82.333 | 0,48% | Saham |
| CITADEL ADVISORS LLC | $406.127 | 79.013 | 0,47% | Saham |
| Jump Financial, LLC | $398.350 | 77.500 | 0,46% | Saham |
| Nuveen, LLC | $254.666 | 49.546 | 0,29% | Saham |
| WOLVERINE TRADING, LLC | $228.312 | 29.346 | 0,26% | Saham |
| ALLIANCEBERNSTEIN L.P. | $220.986 | 23.360 | 0,25% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $210.226 | 40.900 | 0,24% | Saham |
| Bank of New York Mellon Corp | $198.641 | 38.646 | 0,23% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $181.946 | 35.398 | 0,21% | Saham |
| Point72 Asset Management, L.P. | $137.613 | 26.773 | 0,16% | Saham |
| XTX Topco Ltd | $112.181 | 21.825 | 0,13% | Saham |
| JPMORGAN CHASE & CO | $109.932 | 18.507 | 0,13% | Saham |
| Jain Global LLC | $109.482 | 21.300 | 0,13% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $106.532 | 20.726 | 0,12% | Saham |
| RBF Capital, LLC | $102.800 | 20.000 | 0,12% | Saham |
| BANK OF AMERICA CORP /DE/ | $102.085 | 19.861 | 0,12% | Saham |
| RHUMBLINE ADVISERS | $96.688 | 18.812 | 0,11% | Saham |
| WELLS FARGO & COMPANY/MN | $85.797 | 16.692 | 0,10% | Saham |
| Corton Capital Inc. | $85.461 | 10.590 | 0,10% | Saham |
| MILLENNIUM MANAGEMENT LLC | $84.476 | 16.435 | 0,10% | Saham |
| Graham Capital Management, L.P. | $76.884 | 14.958 | 0,09% | Saham |
| CWM, LLC | $76.238 | 8.059 | 0,09% | Saham |
| JANE STREET GROUP, LLC | $69.390 | 13.500 | 0,08% | Opsi beli |
| R Squared Ltd | $68.907 | 13.406 | 0,08% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Chernett Jorey ×2 pengajuan | 2 Okt. 2026 | 0,62% | Amandemen | · | SEC |
| New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell | 20 Feb. 2025 | 7,80% | Amandemen | · | SEC |
| Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 pengajuan | 6 Feb. 2025 | 4,90% | Amandemen | · | SEC |
| New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 pengajuan | 7 Nov. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 11 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Kevin Hykes | PRES & CEO | 27 Feb. 2026 A | 284.237 | 0 | 1 | $-61.328 |
| Nadim Yared | CHIEF EXECUTIVE OFFICER | 2 Feb. 2024 A | 26.255 | 0 | 0 | $0 |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | 27 Feb. 2026 A | 96.703 | 0 | 1 | $-13.778 |
| Brent Binkowski | CHIEF OPERATING OFFICER | 13 Agu 2026 P | 56.514 | 1 | 1 | $72.971 |
| Philip B. Adamson | Chief Medical Officer | 27 Feb. 2026 A | 61.578 | 0 | 1 | $-9.970 |
| Robert Allen John | Chief Revenue Officer | 27 Feb. 2026 A | 86.036 | 0 | 1 | $-31.316 |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | 27 Feb. 2026 A | 60.551 | 0 | 1 | $-10.144 |
| Craig E. Palmer | SVP, U.S. SALES | 25 Maret 2024 M | 1.229 | 0 | 0 | $0 |
| Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | 16 Okt. 2023 M | 778 | 0 | 0 | $0 |
| Dean Bruhn-Ding | VP OF REG. AFFAIRS AND QA | 2 Agu 2022 A | 54.648 | 0 | 0 | $0 |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | 22 April 2022 M | 21.901 | 0 | 0 | $0 |
| Martha Shadan | Direktur | 1 Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mitch C. Hill, | Direktur | 1 Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mudit K. Jain | Direktur | 1 Juni 2026 A | 14.370 | 2 | 0 | $300.432 |
| Kevin J. Ballinger | Direktur | 1 Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Kirk Nielsen | Direktur | 1 Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Ali Behbahani | Direktur | 4 Juni 2024 A | 316 | 0 | 0 | $0 |
| John M Nehra | Direktur | 7 Juni 2022 A | 28.266 | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | Pemilik 10% | 15 Sep. 2023 J | 0 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | Pemilik 10% | 2 Juli 2021 C | 2.026.083 | 0 | 0 | $0 |
| Joseph P Slattery | · | 1 Juni 2026 A | 39.365 | 0 | 0 | $0 |
| DALE MICHAEL D | · | 1 Juni 2026 A | 29.005 | 0 | 0 | $0 |
| Gregory Morrison | · | 2 Maret 2026 A | 34.000 | 0 | 0 | $0 |
| Geoffrey B Pardo | · | 2 Juli 2021 C | 1.829.022 | 0 | 0 | $0 |
| GSK plc | · | 2 Juli 2021 C | 1.007.583 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 14 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 51.258 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,00% | 156.004 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 7.352 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 364.840 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 28.363 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.354 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.299 SH | 3 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 5.367 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 204.533 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 684.121 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 89.003 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 15.722 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.190 SH | 19 Agu 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 31 Juli 2026 | N-PORT |
CVRX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$4.50
+190,3%
3 23,1%
Beli Kuat
6 46,2%
Beli
3 23,1%
Tahan
1 7,7%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
6 analis · 2026-10-03Target rata-rata $4.58 +195,7%
← Di bawah semua target
Harga saat ini $1.55
Rendah$3.50
Rata-rata$4.58
Tinggi$6.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| MDAI | · | · | · | · | · | · |
| ODYS | $54M | -3.1 | -23.9% | -565.0% | -58.7% | 28.9% |
| SRTS | $66M | -8.5 | -34.3% | -28.1% | -15.4% | 43.2% |
| POCI | $56M | -11.9 | 65.2% | -11.5% | -24.5% | 17.2% |
| SNWV | $256M | 72.8 | 35.0% | 26.8% | -395.5% | 77.1% |
| QTI | $73M | -3.0 | 287.9% | -111.4% | -688.9% | 45.4% |
| ARAY | $31M | -0.9 | -12.3% | -12.2% | -103.4% | 27.7% |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026